Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Manx Healthcare launches benzydamine hydrochloride mouthwash

Manx Healthcare has launched a new mouthwash that will be available from pharmacies only.

Oral Soothe and Sore Throat 0.15% w/v Mouthwash contains the active ingredient benzydamine hydrochloride and is aimed at helping consumers to treat mouth and throat pain, according to the manufacturer.

The mouthwash has a pleasant-tasting mint flavour, and it can specifically be used to help with relief of pain caused by a variety of medical issues – including dental surgery, tonsillitis, gum disease, mouth ulcers and other mouth and throat conditions, Manx Healthcare explained.

Brand director Andrew Hawken said the mouthwash “has been developed to provide the consumer and pharmacist with an effective and commercially attractive alternative to add to their therapeutic offering”.

The mouthwash is both an over-the-counter product and a pharmacy (P) medicine, but it will be available in pharmacies only, a spokesperson for the manufacturer explained.

One 300ml bottle retails at £8.90.

To order, call +44 (0)1926 482 511 or email [email protected]


Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts